What are INDmoney investors doing with Par Drugs & Chemicals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-83%
Searches for Par Drugs & Chemicals on INDmoney have decreased by 83% over the last 30 days.
Key Events for Par Drugs & Chemicals
Par Drugs & Chemicals Stock Performance
as on October 30, 2026 at 9:31 pm IST
Day's High
₹114.67₹114.800.11%
Upside

52 Week's Low
52 Week's High
₹78.05₹180.00
31.94%
Downside
56.97%
Upside

Par Drugs & Chemicals share price movements today
- Previous Close
- ₹120.70
- Open
- ₹114.80
- Volume
- 13.91K
- Upper Circuit
- ₹126.73
- Lower Circuit
- ₹114.67
- Day's Low - High
- ₹114.67 - ₹114.80
- 52 Week Low - High
- ₹78.05 - ₹180.00
Par Drugs & Chemicals Historical Returns
- 1 Month Return
- -2.62 %
- 3 Month Return
- + 22.04 %
- 1 Year Return
- + 18.14 %
- 3 Year Return
- -43.72 %
- 5 Year Return
- -45.16 %
Par Drugs & Chemicals Fundamentals
as on October 30, 2026 at 4:01 pm IST
Market Cap
₹141.10 Cr
Return on Equity (ROE)
9.95
PE Ratio (TTM)
11.43
Return on capital employed (ROCE)
14.53
Industry PE ratio
51.65
Beta (LTM)
0.91
P/B Ratio
0.86
Dividend Yield
0PEG Ratio
4.25
Quarterly Earnings Growth YOY
-36.32
EPS (TTM)
0Book Value
0Par Drugs & Chemicals Stock Valuation
as on October 30, 2026 at 4:01 pm IST
Par Drugs & Chemicals in the last 5 years
Lowest (6.77x)
March 28, 2025
Today (11.43x)
October 29, 2026
Industry (51.65x)
October 29, 2026
Highest (39.61x)
October 11, 2021
Today’s Price to Earnings Ratio: 11.43x
Par Drugs & Chemicals Technical Analysis
Track how Par Drugs & Chemicals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | Bullish |
CCI (20) | -35.09 | Neutral |
RSI (14) | 0.02 | Bullish |
Momentum (10) | 0 | Neutral |
ADI (14) | 99.99 | Neutral |
Ultimate Oscillator (7,14,28) | 0 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 114.67 | Neutral |
EMA (20) | 114.67 | Neutral |
VWMA (20) | 114.67 | Neutral |
SMA (50) | 114.67 | Neutral |
EMA (50) | 114.67 | Neutral |
SMA (200) | 114.67 | Neutral |
EMA (200) | 114.81 | |
KAMA (200) | 114.67 | Neutral |
DEMA (200) | 114.31 | Bullish |
Par Drugs & Chemicals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Par Drugs & Chemicals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 141.10 | -9.03% | 0.00 | 13 | 103 | |
| BUY | 703.85 | 6.04% | 0.62 | 29 | 235 | |
| NA | 172.91 | 8.06% | 0.00 | 16 | 85 | |
| NA | 41.35 | -0.31% | 0.00 | 5 | 35 | |
| NA | 137.08 | 17.94% | 0.00 | 4 | 105 |
Par Drugs & Chemicals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Par Drugs & Chemicals Ltd Annual Profit & Loss
Figures in Rupees Crores
Par Drugs & Chemicals Ltd Cash Flow
Figures in Rupees Crores
Par Drugs & Chemicals Corporate Actions
View detailed summary of the earnings and dividend history of Par Drugs & Chemicals.
Par Drugs & Chemicals Ltd Earnings Results
Par Drugs & Chemicals Ltd’s net profit fell -36.32% since last year same period to ₹2.63Cr in the Q2 2026-2027. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated -44.16% fall in its net profits since last 3-months.
Read MorePar Drugs & Chemicals Ltd Dividends November,2021
In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 per share on 09 Nov 2021 - translating a dividend yield of 1.04%.
Read More about Dividends
Insights on Par Drugs & Chemicals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 7 days, PAR stock has moved up by 15.8%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 73.41% of holdings in Jun 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 135.3% return, outperforming this stock by 117.2%
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 520.3% return, outperforming this stock by 564.0%
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 26.59% to 26.51% in Jun 2026 quarter
About Par Drugs & Chemicals Ltd
Revenue: ₹27.43Cr as on September 2026 (Q2 FY27)
Net Profit: ₹2.63Cr as on September 2026 (Q2 FY27)
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
| Organisation | Par Drugs & Chemicals Ltd |
| Industry | Pharmaceuticals |
| CEO | FALGUN VALLABHBHAI SAVANI |
| E-voting on shares | Click here to vote |
FAQs
What is Par Drugs & Chemicals share price today?
Par Drugs & Chemicals share price today stands at ₹114.67 as on at the close of the market. Par Drugs & Chemicals share today touched a day high of ₹114.8 and a low of ₹114.67.
What is the 52 week high and 52 week low range for Par Drugs & Chemicals share?
Par Drugs & Chemicals touched a 52 week high of ₹180 and a 52 week low of ₹78.05. Par Drugs & Chemicals share price today i.e. is closed at ₹114.67, which is -36.29% down from its 52 week high and 46.92% up from its 52 week low.
What is Par Drugs & Chemicals's market capitalisation today?
Par Drugs & Chemicals market capitalisation is ₹141.10 Cr as on .
How to buy Par Drugs & Chemicals shares?
To buy Par Drugs & Chemicals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for PAR or Par Drugs & Chemicals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Par Drugs & Chemicals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Par Drugs & Chemicals trading volume today?
Par Drugs & Chemicals trading volume is 13.91K as on . This means that 13.91K shares of Par Drugs & Chemicals were bought and sold on the stock market during today's trading session.